Pulmonx Corp (LUNG) stock
LUNGNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 3, 2026Score 7/3044% below fair value
$2.73−0.06 (-2.32%)
Close on Nov 17, 2026Market cap $117.46MP/E –Yield –
Pulmonx price to book ratio
The price-to-book ratio is market cap divided by shareholders' equity.
Pulmonx's price to book ratio was 3.3× on Nov 11, 2026, against 1.1× a year earlier. Over the last 5 years it ranged from 1.0× to 5.8×, with a median of 2.7×.
Price to Book Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 3.3× | +1.7 |
| 2025 | Dec 31, 2025 | 1.5× | −1.3 |
| 2024 | Dec 31, 2024 | 2.9× | −1.0 |
| 2023 | Dec 29, 2023 | 3.9× | +2.0 |
| 2022 | Dec 30, 2022 | 1.9× | −3.9 |
| 2021 | Dec 31, 2021 | 5.8× | – |
See a number that looks wrong?